These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20124288)

  • 21. Are methicillin-resistant Staphylococcus aureus that produce Panton-Valentine leucocidin (PVL) found among residents of care homes?
    Smith CS; Parnell P; Hodgson G; Darby B; Barr B; Tompkins D; Heritage J; Wilcox MH
    J Antimicrob Chemother; 2008 Nov; 62(5):968-72. PubMed ID: 18755697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.
    Pitz AM; Yu F; Hermsen ED; Rupp ME; Fey PD; Olsen KM
    J Clin Microbiol; 2011 Jan; 49(1):269-74. PubMed ID: 20962147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
    J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.
    Bernard L; Vaudaux P; Rohner P; Huggler E; Armanet M; Pittet D; Lew DP; Schrenzel J
    J Microbiol Methods; 2004 May; 57(2):231-9. PubMed ID: 15063063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospital.
    Amorim ML; Faria NA; Oliveira DC; Vasconcelos C; Cabeda JC; Mendes AC; Calado E; Castro AP; Ramos MH; Amorim JM; de Lencastre H
    J Clin Microbiol; 2007 Sep; 45(9):2881-8. PubMed ID: 17626175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multilocus sequence typing (MLST) shows that the 'Iberian' clone of methicillin-resistant Staphylococcus aureus has spread to France and acquired reduced susceptibility to teicoplanin.
    Heym B; Le Moal M; Armand-Lefevre L; Nicolas-Chanoine MH
    J Antimicrob Chemother; 2002 Sep; 50(3):323-9. PubMed ID: 12205056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections.
    Tevell S; Claesson C; Hellmark B; Söderquist B; Nilsdotter-Augustinsson Å
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):911-7. PubMed ID: 24338092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis.
    Kirby A; Mohandas K; Broughton C; Neal TJ; Smith GW; Pai P; Nistal de Paz C
    J Med Microbiol; 2009 Mar; 58(Pt 3):376-380. PubMed ID: 19208891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous vancomycin resistance in Staphylococcus aureus: a review of epidemiology, diagnosis, and clinical significance.
    Rong SL; Leonard SN
    Ann Pharmacother; 2010 May; 44(5):844-50. PubMed ID: 20332341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of community-acquired methicillin-susceptible and resistant Staphylococcus aureus isolates recovered from bacteraemic and osteomyelitis infections in children from Tunisia.
    Kechrid A; Pérez-Vázquez M; Smaoui H; Hariga D; Rodríguez-Baños M; Vindel A; Baquero F; Cantón R; Del Campo R
    Clin Microbiol Infect; 2011 Jul; 17(7):1020-6. PubMed ID: 20977540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus.
    Vaudaux P; Ferry T; Uçkay I; François P; Schrenzel J; Harbarth S; Renzoni A
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3367-74. PubMed ID: 22833247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB
    Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Leonard SN; Rossi KL; Newton KL; Rybak MJ
    J Antimicrob Chemother; 2009 Mar; 63(3):489-92. PubMed ID: 19136530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. spa typing of methicillin-resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland.
    Moodley A; Stegger M; Bagcigil AF; Baptiste KE; Loeffler A; Lloyd DH; Williams NJ; Leonard N; Abbott Y; Skov R; Guardabassi L
    J Antimicrob Chemother; 2006 Dec; 58(6):1118-23. PubMed ID: 17030517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Majorcan hospitals: high prevalence of the epidemic clone EMRSA-15.
    Alcoceba E; Mena A; Cruz Pérez M; Ruiz de Gopegui E; Padilla E; Gil J; Ramírez A; Gallegos C; Serra A; Pérez JL; Oliver A
    Clin Microbiol Infect; 2007 Jun; 13(6):599-605. PubMed ID: 17378930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China.
    Wu D; Wang Q; Yang Y; Geng W; Wang Q; Yu S; Yao K; Yuan L; Shen X
    Diagn Microbiol Infect Dis; 2010 May; 67(1):1-8. PubMed ID: 20227225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C; Denis O; Struelens MJ
    Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of the first strain of glycopeptide intermediary Staphylococcus aureus in Tunis Rabta hospital].
    Zribi M; Etienne J; El Euch D; Zribi H; Bes M; Meugnier H; Masmoudi A; Osman AB; Fendri C
    Pathol Biol (Paris); 2011 Dec; 59(6):334-5. PubMed ID: 19942369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.